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Introduction
The three serotypes of poliovirus (PV) are members 
of the family Picornaviridae. The viruses possess a single- 
stranded RNA genome of approximately 7,400 nucleo-
tides (nt). Poliovirus is a causative agent of poliomyeli-
tis, commonly known as polio (Landsteiner and Pop-
per 1909). Polioviruses are transmitted by the fecal-oral 
route, they multiply in the gastrointestinal tract and are 
excreted in large numbers in the feces of infected per-
sons, whether or not they are symptomatic. Virus infects 
sensitive cells of lymphoid tissue in the mouth, nose and 
throat. The incubation period lasts from 2 to 35 days. 
It leads to a transient viremia and the virus spreads to 
the reticuloendothelial system without causing clinical 
symptoms (Sabin, 1956). In very rare cases, 1–2% of 
infected individuals, the virus enters the central nervous 
system (CNS) and replicates in motor neurons within 
the spinal cord, brain stem, or motor cortex. 
The Global Polio Eradication Initiative (GPEI) was 
launched in 1988. The basic strategy involves high levels 
of immunization, routine vaccination and polio virus 
surveillance based on investigation of acute flaccid 
paralysis (AFP) cases. Although AFP surveillance is 
still the gold standard for GPEI, under certain circum-
stances supplementary information can be obtained 
by environmental poliovirus surveillance (ES). The 
rationale for ENV is based on the fact that infected 
individuals, whether they presenting the symptoms or 
not, excrete poliovirus in faeces up to several weeks. ES 
is used for monitoring of PV transmission in human 
populations by examining environmental samples con-
taminated by human faeces. 
About 30 years ago, the effective control of polio-
myelitis was achieved by the introduction of two polio 
vaccines: inactivated poliovirus vaccine (IPV) and 
the oral polio vaccine (OPV), both of which contain all 
three PV serotypes. The OPV consists of live attenu-
ated Sabin strains obtained from wild PVs (Sabin and 
Boulger 1973). Since 2004, three doses of IPV and one 
dose of OPV have been used in Poland. According 
to WHO Global Action Plan III recommendations, 
Poland was obligated to switch to the IPV-only sched-
ule before April 2016. 
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A b s t r a c t
As a complement to the active search for cases of acute flaccid paralysis, environmental sampling was conducted from January to Decem-
ber 2011, to test for any putative polio revertants and recombinants in sewage. A total of 165 environmental samples were obtained and 
analyzed for the presence of polioviruses by use of cell culture (L20B, RD and Caco-2) followed by neutralization and reverse-transcription 
polymerase chain reaction. Out of the 31 CPE positive samples, 26 contained one and 5 two different serotypes, yielding a total of 36 PVs. 
The microneutralization test revealed the presence of 7, 10 and 19 strains belonging to poliovirus serotype 1, 2 and 3, respectively. The 
genomic variability of 36 poliovirus strains was examined by the restriction fragment length polymorphism assay (RFLP). By combined 
analyses of two distant, polymorphic segments of the viral genome, one situated in the capsid protein VP1 coding region and the other 
in the 3D-polymerase coding region, we screened for the putative poliovirus revertants and recombinants. All detected PVs were classi-
fied as vaccine strains on the basis of RFLP-VP1 test. None of wild-type PVs or vaccine derived polioviruses were detected. RFLP assay 
also revealed the presence of 11 recombinants in 3D-polymerase coding region. Nine isolates appeared to be S3/S2, one S3/S1 and S1/S2 
recombinant in analyzed 3Dpol region. This study revealed, through environmental monitoring, the introduction of SL PVs into the popu-
lation associated with the routine use of OPV in Poland before the April 2016. Our findings demonstrate the usefulness of environmental 
surveillance in the overall polio eradication program. 
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Both vaccines (OPV and IPV) provide protection 
from poliomyelitis. However, OPV strains actively mul-
tiply in the gut and induce local secretory IgA response 
that is not seen with IPV. A major problem with the 
OPV is that it is genetically unstable. Sabin strains are 
subject to genetic variation during their replication in 
human intestine. Mutation in VP1 region encoding 
capsid protein may result in recovery of the capacity 
for higher neurovirulence of OPV strains. The neuro-
virulent revertants – vaccine derived polioviruses 
(VDPVs) may cause paralysis in under-immunized 
population and develop sustained circulation. VDPVs 
display 1–15% nucleotide difference within VP1 from 
parental vaccine strain (CDC 2007; Kew et al. 2005). 
Such changes were observed also by alterations of indi-
rect markers such as thermosensitivity (ts-phenotype). 
Higher capacity to replication at supraoptimal tempera-
ture (40°C) of VDPVs and wild type (WT) polioviruses 
has been attributed to the loss of the ts-phenotype (Zur-
briggen et al. 2008). Genetic recombination is another 
mechanism frequently observed in Sabin strains. The 
administration of trivalent OPV provides optimal 
conditions for recombination between heterotypic 
viral genomes. Thus, poliovirus strains are subject to 
genetic variation during their multiplication in humans 
(Kew and Nottay 1984). This prompted the initiation 
of the a study to investigate the prevalence of polio-
virus in sewage samples collected in Poland. The study 
led us to create a comprehensive monitoring system 
for the environmental surveillance of PVs. Our results 
provide valuable information about the prevalence of 
PVs in sewage samples collected from 14 locations in 
Poland during 12-month period. Our study highlights 
the importance of environmental surveillance for detec-
tion of PVs during the OPV-to-IPV transition period.
Experimental
Materials and Methods
Sewage samples. A total of 165 raw sewage samples 
were collected between January and December 2011, 
one sample per month, from 14 sewage disposal sys-
tems in Poland. The sample-processing protocol has 
been described earlier (Zurbriggen et al., 2008). To 
describe the process briefly, AlCl3 (final concentration, 
0.5 mM) was added to 500 ml of sewage sample, and 
the pH was adjusted to 3.5. Following the addition of 
250 µl of an SiO2 slurry, the samples were stirred for 
30 min followed by centrifugation at room tempera-
ture and 1500 × g for 10 min to pellet the SiO2. The 
virus was recovered by rocking the pellet for 20 min 
with 3 ml of 50 mM glycine (pH 9.5) containing 3% 
(wt/vol) beef extract. After centrifugation for 5 min 
at 4°C and 1500 × g, the supernatants were treated 
with 3 ml chloroform with rocking for 20 min. After 
a  final centrifugation, the concentrates were used to 
inoculate cell cultures.
Isolation and identification of viruses. RD, L20B 
and Caco-2 cells were used throughout the experiment. 
RD and L20B cells were cultivated in minimal essential 
medium supplemented adequately with 3.5 and 10% 
fetal bovine serum (FBS). Caco-2 cells were cultivated 
in EMEM supplemented with 10% FBS. A volume of 
200 µl sewage concentrate was inoculated into tubes 
with RD and L20B cells according to WHO procedure 
(WHO 2004) and additionally into tubes with Caco-2 
cells. The tubes were incubated for 7 days at 36°C and 
examined daily for the appearance of cytopathic effect 
(CPE). After 7 days, the tubes were frozen at –20°C, 
thawed and 200 µl volumes passaged in cultures of the 
same cell type. Each specimen underwent three pas-
sages in RD, L20B and Caco-2 cells. Isolates obtained 
from specimens that are negative in L20B cells but posi-
tive in RD or Caco-2 cell line were repassaged in L20B 
to include the possibility of poliovirus. Samples dem-
onstrating characteristic viral CPE were identified by 
neutralization assay using a selected set of polyclonal 
antisera against poliovirus type 1, 2 and 3 developed 
by National Institute of Public Health and the Environ-
ment, the Netherlands. The typing of polioviruses was 
performed according to WHO polio laboratory manual 
(WHO 2004). Briefly, using the micro-neutralization 
(microtitre plate) technique, the serum/isolate mixtures 
are incubated for one hour at 36°C to allow the anti-
bodies to bind to the virus. Subsequently, suspensions 
of L20B cells are added to the microtitre plates which 
are examined daily for the presence of CPE. The anti-
serum that prevents the development of CPE indicates 
the identity of the virus. 
Molecular characterization of viruses. Viral RNA 
was purified from supernatants of tubes that showed 
cytophatic effect, using Qiamp Viral RNA Mini Kit 
following the manufacturer’s instructions. RT-PCR 
for intratypic differentiation (ITD) was carried out 
with Sabin-type specific primers according to WHO 
manual (WHO 2004). Three primer pairs (Sabin1.re/
Sabin1.fw, Sabin2.re/Sabin2.fw, Sabin3.re/Sabin3.fw) 
targeting the sequence of VP1 region characteristic for 
each Sabin strain. These primers allow the amplifica-
tion of genomic fragments of 97 bp, 71 bp, 53 bp from 
PV Sabin 1, Sabin 2 and Sabin 3 strains, respectively. 
RT-PCR was performed: 1 cycle of reverse transcription 
at 45°C for 20 min; 1 cycle of denaturation at 94°C for 
2 min; 30 cycles of denaturation at 94°C for 30 s, anneal-
ing at 55°C for 30 s, elongation at 70°C for 30 s followed 
by 1 cycle of elongation at 70°C for 7 min. Amplifica-
tion products were analyzed in 2% agarose gels, stained 
with GelRed and visualized under UV light. 
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Restriction Fragments Length Polymorphism 
(RFLP) assays. Recombinant genomes were detected 
with a double RFLP assay that was performed as 
described elsewhere (Balanant et al. 1991, Furione et al. 
1993) with slight modifications. Briefly, two distant 
regions of the viral genome were subjected to RT-PCR 
amplification followed by restriction enzyme digestion. 
The first pair of primers UC1 and UG1 was used for 
amplification of a 480 bp segment in VP1 capsid-encod-
ing region in the RFLP-VP1 test. Another set of primers 
UC8 and UG7, was used to amplify a 291 bp segment in 
the 3D polymerase-coding region (RFLP-3D assay). The 
one step RT-PCR amplification was performed: 1 cycle 
of reverse transcription at 42°C for 30 min, 1 cycle of 
denaturation at 94°C for 2 min, 30 cycles of denaturation 
at 94°C for 10s, annealing at 45°C for 60 s, elongation at 
70°C for 60s followed by 1 cycle of elongation at 70°C 
for 5 min. Amplification products of 490 bp and 291 bp 
were analyzed in 2% agarose gels, stained with GelRed 
and visualized under UV light. 
Restriction enzymes were selected to differentiate 
between the genomes of the recombinants and the 
parental Sabin strains. RFLP-VP1 patterns of poliovirus 
strains were obtained by digesting a fraction of 480 bp 
amplified fragment with HaeIII (10U), DdeI (5U) and 
HpaII (14U). The 291 bp amplicon was digested by 
HaeIII (10U), DdeI (10U) and RsaI (10U) to obtain the 
RFLP-3D profiles. Reaction mixtures were incubated 
overnight at 37°C and digestion products were analyzed 
by electrophoresis in 3% agarose gel.
Determination of temperature sensitive (ts) phe-
notype. Tubes with confluent monolayer of L20B cells 
were inoculated with 200 µl of undiluted virus stocks: 
poliovirus isolates (no 1–36) and Sabin 1, 2 and 3 strains. 
After adsorption for 1 h at 36°C or 40°C, the unabsorbed 
virus inoculum was removed. The maintenance medium 
was added and the tubes were incubated in parallel at 
36°C or 40°C. After 24 h, the tubes were frozen and 
thawed three times. The infectivity of isolates and Sabin 
strains was measured by titration on L20B cells accord-
ing to WHO procedure (WHO 2004). In a previous 
study Zubriggen et al. (2008) showed a titer reduction 
of 2 log10 units with reference wild type PV1/Mahoney 
strain. Therefore, the titer reduction of > 2 log10 units 
was considered to reflect temperature sensitivity.
Results
Isolation and identification of polioviruses. The 
wastewater samples were collected monthly from 
14  sampling sites in Poland between January and 
December, 2011. In total, 31 out of 165 (18.8%) sewage 
samples were positive for poliovirus isolation in L20B, 
RD, Caco-2 cells and resulted in recovery of 36  PV 
strains. Polioviruses were isolated from samples col-
lected in all months except April, May and June (Fig. 1). 
The highest monthly percentage of positive samples was 
observed in December (57.1%) and September (42.9%). 
The percentage of samples positive in cell culture 
Fig. 1. Seasonal distribution of polioviruses isolated in cell culture from sewage samples in Poland.
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isolation at the different sampling sites ranged between 
8.3% and 50.0% (Fig. 1). 
Out of the 31 CPE positive samples, 26 contained 
one and 5 two different serotypes, yielding a total of 
36  PVs. All poliovirus strains were isolated in three 
cell lines: L20B (17 strains), RD (2 strains) and Caco-2 
(17  strains). The identification of poliovirus isolates, 
was performed using a selected set of polyclonal anti-
sera against poliovirus types 1, 2 and 3. The micro-
neutralization test revealed the presence of 7, 10 and 
19 strains belonging to poliovirus serotype 1, 2 and 3, 
respectively. 
Intratypic differentiation of polioviruses. Further 
characterization of isolates was carried out by intratypic 
differentiation using Sabin type-specific primers. The 
results obtained by RT-PCR assay for ITD confirmed 
the serotypes identified in microneutralization test and 
showed that all isolates are poliovirus Sabin-like (SL) 
strains (Table I).
Most of identified PVs come from samples collected 
during the June-December period (Fig. 1). The most 
frequently identified PV type 3 was detected in the fol-
lowing months: January, February, June, August (7.1%), 
September (21.4%), October (23.1%) and November 
(7.1%) with a peak on December (57.1%). Detection of 
PVs type 2 was mainly observed from July to Decem-
ber. PVs type 1 were isolated almost on the same level as 
PVs type 2, without a clear peak. All samples collected 
in March, April and May were negative for polioviruses. 
The geographical distribution of polioviruses identi-
fied in sewage samples is shown in Figure 2. The num-
ber of detected PVs differed from 8 to 1, depending on 
the sampling site.
Determination of ts phenotype. In contrast to WT 
polioviruses, SL strains display ts phenotype and do 
not grow well at the elevated temperature of 40°C. For 
this reason, all isolates were tested for the replication 
capacity in supraoptimal temperature. Almost all polio-
virus strains were temperature sensitive as expected, 
with titer reduction of ~ 2 log10 in 36°C/40°C. Only two 
strains showed < 2 log10 reduction in titer.
Identification of vaccine (Sabin) origin by RFLP-
VP1. The vaccine origin of isolates was determined 
first by ITD assay. To confirm the vaccine origin of 
the strains, viral genomes were analyzed by RFLP-VP1 
test. A 480-nucleotide fragment in the VP1 capsid 
protein-coding region was amplified by PCR from the 
viral genome. RFLP patterns specific for the isolates 
were generated by digestion of the PCR product with 
HaeIII, DdeI, and HpaII endonucleases and compared 
with the patterns obtained with the reference strains: 
Sabin type 1, 2, 3 (Table I). The RFLP profiles of all iso-
Fig. 2. Geographical distribution of polioviruses identified in sewage samples in Poland.
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lates, after cleavage with 3 endonucleases were identical 
to those of the Sabin type 1, 2 and 3 reference strains. 
However, one exception was recorded. The restriction 
profiles after cleavage with DdeI and HpaII of the strain 
25 were similar to those obtained with Sabin 3. Cleav-
age with HaeIII yielded one additional DNA fragment 
(< 300 bp), different from those obtained with Sabin 3. 
This RFLP pattern may suggest genetic variation and 
introduction additional restriction site recognized by 
endonuclease HaeIII.
1/VIII CaCo-2 Gdynia S1 S1 S1 S1 S1 S1 S1
2/VII L20B Jelenia Góra S1 S1 S1 S1 S1 S1 S2
3/I L20B Opole S1 S1 S1 S1 S1 S1 S1
4/IX RD Opole S1 S1 S1 S1 S1 S1 S1
5/X L20B Opole S1 S1 S1 S1 S1 S1 S1
6/IX CaCo-2 Pilchowice S1 S1 S1 S1 S1 S1 S1
7/IX L20B Pilchowice S1 S1 S1 S1 S1 S1 S1
Control strain: PV Sabin 1 S1 S1 S1 S1 S1 S1 S1
8/VIII CaCo-2 Białystok S2 S2 S2 S2 S2 S2 S2
9/VII RD Bielsko-Biała S2 S2 S2 S2 S2 S2 S2
10/XII CaCo-2 Chełm S2 S2 S2 S2 S2 S2 S2
11/XI CaCo-2 Gdynia S2 S2 S2 S2 S2 S2 S2
12/I L20B Mińsk Maz. S2 S2 S2 S2 S2 S2 S2
13/IX L20B Mińsk Maz. S2 S2 S2 S2 S2 S2 S2
14/X CaCo-2 Opole S2 S2 S2 S2 S2 S2 S2
15/I L20B Pilchowice S2 S2 S2 S2 S2 S2 S2
16/VII CaCo-2 Pilchowice S2 S2 S2 S2 S2 S2 S2
17/XII CaCo-2 Pilchowice S2 S2 S2 S2 S2 S2 S2
Control strain: PV Sabin 2 S2 S2 S2 S2 S2 S2 S2
18/XII CaCo-2 Chełm S3 S3 S3 S3 S3 S3 S3
19/XII CaCo-2 Gdynia S3 S3 S3 S3 S2 S2 S2
20/XII L20B Gdynia S3 S3 S3 S3 S2 S2 S2
21/IX L20B Koszalin S3 S3 S3 S3 S3 S3 S3
22/XII L20B Koszalin S3 S3 S3 S3 S2 S2 S2
23/XII CaCo-2 Opole S3 S3 S3 S3 S3 S3 S3
24/II CaCo-2 Pilchowice S3 S3 S3 S3 S2 S2 S2
25/X CaCo-2 Pilchowice S3 S3 S3 S3 S2 S2 S2
26/X L20B Pilchowice S3 S3 S3 S3 S3 S3 S3
27/VI L20B Piotrków Tryb. S3 S3 S3 S3 S3 S3 S3
28/IX L20B Piotrków Tryb. S3 S3 S3 S3 S1 S1 S1
29/IX L20B Radom S3 S3 S3 S3 S3 S3 S3
30/XII L20B Radom S3 S3 S3 S3 S3 S3 S3
31/XI CaCo-2 Radom S3 S3 S3 S3 S3 S3 S3
32/X CaCo-2 Warka S3 S3 S3 S3 S2 S2 S2
33/I L20B W-wa Czajka S3 S3 S3 S3 S2 S2 S2
34/XII L20B W-wa Czajka S3 S3 S3 S3 S2 S2 S2
35/VIII CaCo-2 W-wa Płd. S3 S3 S3 S3 S3 S3 S3
36/XII CaCo-2 W-wa Płd. S3 S3 S3 S3 S2 S2 S2
Control strain: PV Sabin 3 S3 S3 S3 S3 S3 S3 S3
Table I
Polioviruses identified in sewage samples in Poland.
S1, S2, S3: Poliovirus Sabin type 1, 2 and 3, respectively.
Isolate
no./Month Cell line City ITD
RFLP assay
RFLP-VP1 RFLP-3D
HaeIII RsaIDdeIHaeIIIHpaIIDdeI
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Detection of recombinant strains by RFLP-3D. We 
screened for recombinant strains by RFLP-3D assay, 
which analyzes the 5’ part of the 3D polymerase cod-
ing region. RFLP-3D profiles were generated by diges- 
tion of the 291 bp PCR product with HaeIII, DdeI, and 
RsaI endonucleases and compared with the patterns 
obtained with the reference strains: Sabin type 1, 2, 3 
(Table I). Among the 7 strains belonging to PV1, 6 had 
RFLP-3D profiles similar to those obtained with the 
Sabin 1. One strain (2) had restriction profile similar to 
those of the Sabin 2 with one of the three endonucleases 
used (RsaI), which strongly suggested the it relatedness 
to the Sabin 2. None of the serotype 2 strains was found 
to have a recombinant genome. Out of the 19  Sabin 
3-derived strains, only 9 had restriction profiles iden-
tical to those obtained with Sabin 3. Nine strains (19, 
20, 22, 24, 25, 32, 33, 34, 36) had RFLP-3D profiles 
indistinguishable from those obtained with Sabin  2, 
suggesting that their genomes consisted of segments 
derived from both Sabin 3 and Sabin2. One strain (28) 
had restriction profile obtained after digestion with 
three endonucleases, identical to those of the Sabin 1, 
suggesting close relatedness.
Discussion
Environmental surveillance has been used success-
fully in monitoring poliovirus circulation and assessing 
the extent or duration of epidemic poliovirus circula-
tion in specific populations. In several countries, wild 
polioviruses and VPDVs have been detected in the sew-
age, sometimes in the absence of reported AFP cases. 
The list of countries routinely employing environmental 
surveillance includes Czech Republic, Egypt, Estonia, 
Finland, India, Israel, Japan, Latvia, The Netherlands, 
New Zealand, Pakistan, Russia, Slovakia and Switzer-
land. In Finland and Israel it is considered to be the 
main approach of PV surveillance (Hovi et al., 2010). 
Polioviruses are frequently isolated from sewage sam-
ples in countries using OPV in routine immunization 
schedule. In Finland, where IPV is used exclusively for 
polio immunization, Sabin strains are isolated from 
environmental samples annually. This phenomenon 
involves traveling tourists from neighbouring Estonia 
and Russia, where OPV has been used recently. Moreo-
ver, importations of wild polioviruses was documented 
by ENV in the Israel and Gaza district in the absence 
of AFP cases (Manor et al., 1999; Manor et al., 2007). 
As a complement to the active search for cases of AFP, 
ENV has a role in the new WHO strategy (The Global 
Polio Eradication Strategic Plan, 2010–2012) for inten-
sified efforts to complete poliomyelitis eradication.
After eradication of WPV transmission, the risk of 
re-emerge of polio remains is high (especially for under-
immunized populations) as long OPV continues to be 
used routinely. Attenuated strains of the Sabin OPV tend 
to vary during their natural multiplication in the human 
gut and in rare cases cause vaccine-associated paralytic 
poliomyelitis (VAPP). Thus oral polio vaccine provides 
a potential source of circulating neurovirulent VDPV 
strains. Environmental contamination with feces and 
increasing use of wastewater in agriculture are likely 
risk factor for transmission of PVs (Dowdle et al., 
2006). Highly divergent and neurovirulent VDPVs have 
been isolated from sewage samples in several countries: 
Greece, Finland, Slovakia, Switzer land (Dedepsidis 
et al., 2007; Roivainen et al., 2010; Cernáková et al., 
2005). ENV can be important tool for monitoring the 
emergence of VDPVs, re-emergence of WT PVs or dis-
appearance of Sabin strains after OPV cessation. 
The present study used SiO2-based protocol for con-
centration of sewage samples, followed by isolation of 
viruses in cell lines: L20B, RD and Caco-2. Compared to 
other methods of concentration, this protocol is simple, 
fast and easy to implement in environmental microbio-
logy, especially for large volumes of the analyzed sam-
ples. Moreover, Zurbriggen et al. demonstrated a higher 
recovery rate (60%) in silicon dioxide assay than the 
two-phase separation protocol (30%) recommended by 
WHO (WHO 2003). 
Culture-based systems for virus isolation have been 
the “gold standard” in clinical virology for decades. 
Although this technique is often slow and requires con-
siderable technical expertise, WHO recommends L20B 
and RD cell lines for isolation of polioviruses (WHO 
2004). In this study, Caco-2 cell line was used to obtain 
the maximum sensitivity for isolation of poliovirus 
from the sewage samples. Our earlier studies and other 
authors showed that Caco-2 cell line support growth 
of astroviruses, adenoviruses, rotaviruses and entero-
viruses including poliovirus (Hamza et al., 2011; Pinto 
et al., 1995; Wieczorek et al., 2013). In total, we isolated 
36 poliovirus strains out of 165 (isolation rate 18.78%) 
sewage samples in L20B, RD, Caco-2 cells. Interestingly, 
47% of poliovirus strains were isolated in Caco-2 cell 
line. The use of Caco-2 in the present study significantly 
increased the poliovirus detection. 
The seasonal distribution of polioviruses is well 
documented, its presence being common in the late 
summer and fall. In our study the distribution of PVs 
followed the seasonal pattern with a clear peak in Sep-
tember and December. Polioviruses were isolated from 
samples collected in all sampling sites during 12-month 
period except April, May and June. In fact, scheduled 
OPV immunizations determine the frequency of Sabin-
like PVs isolation. Other studies have reported a rapid 
decline in PV isolation around OPV-to-IPV transition 
period, with a dissappearance of PV vaccine strains 
from wastewater within 2 to 3 months after the cessa-
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tion of OPV administration (Mueller et al., 2009; Waha-
juhono et al., 2014). 
The serotypes of the isolates were determined by the 
microneutralization assays. The serotyping test revealed 
the presence of 7 and 10 strains belonging to polio-
virus serotype 1, 2 respectively. The most frequently 
detected polioviruses were PV3 (19 strains) and these 
accounted 53% of total serotyped strains. Other authors 
also indicate that PV3 is frequently isolated from sew-
age samples (Sarijlou et al., 2007; Yoshida et al., 2000). 
In previous studies Stanway et al. (1984) showed that 
the difference between attenuated Sabin 3 and wild-
type PV3 Leon strains is restricted to only 10 nucleo-
tides and three amino acids. In addition, it has been 
shown that P1 domain of PV3 Sabin strain harbors only 
two nucleotide changes correlating with the apparent 
mitigation of neurovirulence. Therefore, most cases of 
VAPP result from vaccination with PV3 (Minor 2004). 
Mutations known to be involved in restoring neu-
rovirulence or eliminating the temperature-sensitive 
phenotype of vaccine derivatives are associated with 
capsid coding region of poliovirus genome (Macadam 
et al., 1989; Westrop et al., 1989; Ren et al., 1991; Maca-
dam et al., 1993). The ts phenotype correlates with the 
attenuated Sabin strains. A titer reduction of > 2 log10 
units at 40°C is considered to reflect temperature sen-
sitivity (Zubriggen et al., 2008). In the present study 
we showed a ≥ 2 log10 reduction in titer for most of 
poliovirus isolates propagated at 40°C. All analyzed 
isolates grew poorly in supraoptimal temperature, 
what is characteristic for Sabin-like strains. Similar 
findings presented by other authors, also demonstrate 
that ts is an important viral phenotypic marker, as it 
may be involved in virulence of attenuated vaccine 
strains (Blomqvist et al., 2003; Zurbriggen et al., 2008). 
On the other hand, Bouchard et al. (1995) suggest that 
temperature sensitivity may not always be an accept-
able method for evaluating the presence of attenuating 
mutations. Although intratypic differentiation revealed 
the presence of 36 SL PVs, two strains showed < 2 log10 
reduction in titer. Our results also show that that deter-
minants of attenuation and temperature sensitivity can 
be genetically separated.
Recombination is a very frequent event in poliovi-
rus evolution (Agol 2006). Moreover, the trivalent OPV 
provides ideal conditions for intertypic recombination 
between the attenuated strains of the three PV sero-
types. In order to understand the evolution of vaccine 
strains during their replication in humans, our study 
focused on the characterization of PV genomes by dou-
ble RFLP assay and revealed the presence of 11 recom-
binants in 3D-polymerase coding region. Nine isolates 
appeared to be S3/S2, one S3/S1 and S1/S2 recombinant 
in analyzed 3Dpol region. The low degree of changes 
found in the genome of the 36 SL PVs may suggest that 
these strains have undergone only limited circulation 
in the population.
In summary, the isolation of 36 SL PVs demonstrated 
that environmental surveillance is an effective supple-
mental support to the AFP surveillance to verify the 
absence of wild or VDPV strains in the country. No WT 
and VDPV strains were isolated from the environmental 
samples examined during the study period. In Slovakia, 
high percentage of PV strains (SL and VDPV) were also 
observed in sewage water during 2001–2006. Thereafter, 
PV isolates were gradually replaced by non-polio enter-
oviruses (NPEVs). A transition was due to the change 
in the childhood vaccination programme in which OPV 
was substituted by IPV (Klement et al., 2013). In con-
trast, other authors have showed the dis appearance of SL 
PVs from the environment even before the OPV immu-
nization has ceased (Nakamura et al., 2015). 
In conclusion, our study revealed, through environ-
mental monitoring, the introduction of SL PVs into the 
population associated with the routine use of OPV in 
Poland before the April 2016. Detection of polioviruses 
in sewage samples of the local community reflects the 
presence of virus-shedding individuals. ENV should be 
continued in the critical period between interruption of 
WPV transmission and certification of polio eradica-
tion. Environmental surveillance should be also avail-
able in the post-eradication and OPV cessation periods. 
Even if the OPV-to-IPV transition is successful, the risk 
of PV infection for a susceptible population should be 
monitored with an appropriate surveillance system. 
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